Conventional and intravenous immunoglobulin therapy in paediatric antiphospholipid antibodies-related chorea

Claudia Brogna, Paolo Mariotti, Raffaele Manna

Research output: Contribution to journalEditorialpeer-review

12 Citations (Scopus)

Abstract

Chorea is the most common movement disorder associated to autoimmune diseases and one of the first non thrombotic neurological complications associated with antiphospholipid antibodies (aPL). Several treatment options have been considered, especially in young patients that failed to respond to conventional therapy. In the last years Intravenous immunoglobulin treatment (IVIG) are largely administered with beneficial and rapid effect not only in adult patients affected by autoimmune diseases, but also in children. IVIG treatment could be considered as therapeutic option also in children with antiphospholipid related chorea.
Original languageEnglish
Pages (from-to)1449-1451
Number of pages3
JournalLupus
Volume23
DOIs
Publication statusPublished - 2014

Keywords

  • chorea
  • immunoglobulin

Fingerprint

Dive into the research topics of 'Conventional and intravenous immunoglobulin therapy in paediatric antiphospholipid antibodies-related chorea'. Together they form a unique fingerprint.

Cite this